<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-RNFS7S2S</identifier><date>2014</date><creator>Kovačič, Sašo</creator><creator>Premuš Marušič, Alenka</creator><relation>documents/doc/R/URN_NBN_SI_doc-RNFS7S2S_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-RNFS7S2S_001.txt</relation><format format_type="issue">1</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 45-48</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3626353</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-RNFS7S2S</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">antipsihotiki</subject><subject language_type_id="slv">farmacevt svetovalec</subject><subject language_type_id="slv">interakcije med zdravili</subject><title>Clinical case example of a clinical pharmacist - consultant</title><title>Klinični primer iz prakse kliničnega farmacevta - svetovalca</title></Record>